Execution Summary
- Study: Study 41: Oncology Cohort
- Owner: Daniel Osei
- Status: completed
- Started: 2025-03-13T00:00:00.000Z
- Samples: 5
- Assay runs: 1 (1 open)
Experiment EX-0290
Hide
Execution notebook with protocol context, sample traceability, run outcomes, and downstream readiness checks. Business and scientific purpose: improve experimental quality, reproducibility, and cycle time from design to validated evidence. Experiment EX-0290 is connected to linked entities, metrics, and workflow actions in this workspace. Use these panels to review evidence, identify risks, and decide the next best scientific action. The view uses deterministic demo data shaped to mirror realistic drug discovery operations.
Protocol Context
- Protocol: Cell Prep 15
- Version: v2.9
- Effective date: 2025-08-19T00:00:00.000Z
- Signed by: Dr. Alice Morgan